Renaissance Capital logo

Population Health Investment Priced, Nasdaq: PHICU

Blank check company targeting a therapeutics business (liquidated).

Industry: SPAC

First Day Return: +0.6%

Industry: SPAC

We are a newly incorporated blank check company. We have not selected any specific business combination target. While we may pursue an initial business combination in any industry, sector, or geographic region, we will focus on companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. We intend to capitalize on the unique mix of experience and highly-complementary capabilities of our co-founders, Clive Meanwell and Ian Read, as well as our management team, in leading, operating and strategically positioning global companies in that sector, as well as investing and managing capital, structuring transactions and building businesses. We believe that our industry knowledge and operating experience, in addition to our co-founders’ reputations and strong track record of creating shareholder value, make us a partner of choice for owners and management teams of highly attractive private companies. We believe that the vast networks of relationships of our founders, management team and board of directors will provide us with a significant competitive advantage in sourcing a pipeline of potential opportunities that may not be available to others.
more less
IPO Data
IPO File Date 10/30/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 15.0
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/17/2020
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $150
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters New York, NY, United States
Founded 2020
Employees at IPO 2

Population Health Investment (PHICU) Performance